DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 198 filers reported holding DEPOMED INC in Q1 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,621,000 | -12.0% | 311,936 | +22.0% | 0.01% | -12.5% |
| Q3 2016 | $6,384,000 | +27.3% | 255,655 | +0.0% | 0.01% | +33.3% |
| Q2 2016 | $5,013,000 | +61.9% | 255,528 | +14.9% | 0.01% | +50.0% |
| Q1 2016 | $3,097,000 | -23.8% | 222,335 | -0.8% | 0.00% | -20.0% |
| Q4 2015 | $4,062,000 | -4.2% | 224,059 | -0.4% | 0.01% | -16.7% |
| Q3 2015 | $4,241,000 | -14.6% | 224,976 | -2.8% | 0.01% | 0.0% |
| Q2 2015 | $4,965,000 | +9.2% | 231,364 | +14.0% | 0.01% | 0.0% |
| Q1 2015 | $4,548,000 | +41.4% | 202,929 | +1.6% | 0.01% | +50.0% |
| Q4 2014 | $3,217,000 | +5.5% | 199,680 | -0.6% | 0.00% | 0.0% |
| Q3 2014 | $3,050,000 | +30.6% | 200,801 | +19.5% | 0.00% | +33.3% |
| Q2 2014 | $2,335,000 | +2.7% | 167,987 | +7.2% | 0.00% | 0.0% |
| Q1 2014 | $2,273,000 | +38.3% | 156,754 | +0.9% | 0.00% | +50.0% |
| Q4 2013 | $1,644,000 | +37.5% | 155,421 | -2.9% | 0.00% | 0.0% |
| Q3 2013 | $1,196,000 | +40.2% | 160,077 | +5.5% | 0.00% | 0.0% |
| Q2 2013 | $853,000 | – | 151,726 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DELTEC ASSET MANAGEMENT LLC | 1,876,195 | $42,045,000 | 9.16% |
| Senvest Management, LLC | 3,331,531 | $74,660,000 | 4.62% |
| Krensavage Asset Management, LLC | 343,546 | $7,699,000 | 3.51% |
| PERKINS CAPITAL MANAGEMENT INC | 97,950 | $2,195,000 | 1.84% |
| HAYS ADVISORY LLC | 580,069 | $12,999,000 | 1.68% |
| ARBOR CAPITAL MANAGEMENT LLC | 572,200 | $12,823,000 | 1.54% |
| Broadfin Capital, LLC | 705,204 | $15,804,000 | 1.23% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 556,311 | $13,969,000 | 1.14% |
| Pier Capital, LLC | 330,682 | $7,411,000 | 1.12% |
| TURNER INVESTMENTS LLC | 259,357 | $5,812,000 | 1.04% |